Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail

Journal of Clinical Investigation

Volumn 101, Issue 4, 1998, Pages 827-833

  Kikuchi, Tateki ^b   Yang, Helen Wen ^a   Pennybacker, Mark ^a   Ichihara, Nobutsune ^b   Mizutani, Makoto ^c   Van Hove, Johan L K ^a   Chen, Yuan Tsong ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^c NIPPON INSTITUTE FOR BIOLOGICAL SCIENCE   (Japan)

Author keywords

Acid maltase deficiency; Acid glucosidase; Enzyme replacement therapy; Japanese quail; Pompe disease

Indexed keywords

ALPHA GLUCOSIDASE; GLUCAN 1,4 ALPHA GLUCOSIDASE; GLYCOGEN; RECOMBINANT ENZYME; RECOMBINANT GLUCAN 1,4 ALPHA GLUCOSIDASE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME THERAPY; GLYCOGEN STORAGE DISEASE TYPE 2; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUSCLE FUNCTION; MUSCLE STRENGTH; NONHUMAN; PRIORITY JOURNAL; QUAIL;

EID: 0032519686     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1722     Document Type: Article

References (36)

1. Hershfield, M.S., R.H. Buckley, M.L. Greenberg, A.L. Melton, R. Schiff, C. Hatem, J. Kurtzberg, M.L. Markert, R.H. Kobayash, et al. 1987. Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N. Engl. J. Med. 316:589-596.
2. Wewers, M.D., M.A. Casolaro, S.E. Sellers, S.C. Swayze, K.M. McPhaul, J.T. Wittes, and R.G. Crystal. 1987. Replacement therapy for α-antitrypsin deficiency associated with emphysema. N. Engl. J. Med. 316:1055.
3. Kazazian, H.H., E.G.D. Tuddenham, and S.E. Antonarakis. 1995. Hemophilia and parahemophilia: deficiencies of coagulation factors VIII and V. In The Metabolic and Molecular Basis of Inherited Disease, 7th edition. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle. editors. McGraw-Hill, Inc., New York. 3341-3267.
4. Barton, N.W., F.S. Furbish, G.J. Murray, M. Garfield, and R.O. Brady. 1990. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc. Natl. Acad. Sci. USA. 87:1913-1916.
5. Hirschhorn, R. 1995. Glycogen storage disease type II: acid a-glucosidase (acid maltase) deficiency. In The Metabolic and Molecular Basis of Inherited Disease, 7th edition. CR. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, editors. McGraw-Hill, Inc., New York. 2443-2464
6. Watson, J.G., D. Gardner-Medwin, M.E. Goldfinch, A.D.J. Pearson. 1986. Bone marrow transplantation for glycogen storage disease type II (Pompe's disease). N. Engl J. Med. 314:385.
7. Harris, R.E., D. Hannon, C. Vogler, and G. Hug. 1986. Bone marrow transplantation in type IIa glycogen storage disease. In Bone Marrow Transplantation for Treatment of Lysosomal Storage Diseases. W. Krivit and N.W. Paul, editors. Alan R. Liss, New York. 119-132.
8. Hug, G., and W.K. Schubert. 1967. Hepatic lysosomes in Pompe's disease: disappearance during glucosidase administration. J. Clin. Invest. 46:1073.
9. Lauer, R.M., T. Mascarinas, A.S. Racela, A.M. Diehl, and B.I. Brown. 1968. Administration of a mixture of fungal glucosidases to a patient with type II glycogenosis (Pompe disease). Pediatrics. 42:672.
10. de Barsy, T., P. Jacquemin, F. Van Hoof, and H.-G. Hers. 1973. Enzyme replacement in Pompe disease: an attempt with purified human acid α-glucosidase. Birth Defects Orig. Artic. Ser. 9:184-190.
11. Williams, J.C., and A.K. Murray. 1980. Enzyme replacement in Pompe disease with an alpha glucosidase low-density lipoprotein complex. In Enzyme Therapy in Genetic Diseases: II. Alan R. Liss, New York. 415-123.
12. Van Hove, J.L.K., H.W. Yang, J.-Y. Wu, R.O. Brady, Y.-T. Chen. 1996. High level production of recombinant human lysosomal acid α-glucosidasc in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease. Proc. Natl. Acad. Sci. USA. 93:65-70.
13. Fullar, M., A. Van Der Ploeg, A.J.J. Reuser, D.S. Anson, and J.J. Hopwood. 1996. Isolation and characterization of a recombinant precursor form of lysosomal acid alpha-glucosidase. Eur: J. Biochem. 234:903-909.
14. Richards, R.B., J.R. Edwards, R.D. Cook, and R.R. White. 1977. Bovine generalized glycogenosis, Neuroptithol, Appl. Neurobiol. 3:45-56.
15. Howell, J.M., P.R. Dorling, R.D. Cook,. W.F. Robinson, S. Bradley, J.M. Gawthorne. 1981. Infantile and late onset form of generalised glycogenosis type II in cattle. J. Pathol. 134:267-277.
16. O'Sullivan, B.M., P.J. Healy, R.E. Fraser, R.E. Nieper, R.J. Whittle, and C.A. Sewell. 1981. Generalized glycogenosis in Brahman cattle. Aust. Vet. J. 57: 227-229.
17. Murakami, H., A. Takagi, S. Nanaka, S. Ishiura, and H. Sugita. 1980. Glycogenosis II in Japanese quails. Exp. Anim. (Tokyo). 29:475-485.
18. Murakami, H., A. Takagi, I. Nonaka, S. Ishiura, H. Sugita, and M. Mizutani. 1982. Type 2 glycogen storage disease in Japanese quail. In Muscular Dystrophy. S. Ebashi, editor. University of Tokyo Press, Tokyo. 37-48.
19. Usuki, F., S. Ishiura, and H. Sugita. 1986. Developmental study of α-glucosidase in Japanese quails with acid maltase deficiency. Muscle Nerve. 9:537-543.
20. Higuchi, I., I. Nonaka, F. Usuki, S. Ishiura, and H. Sugita. 1987. Acid maltase deficiency in the Japanese quail: early morphological event in skeletal muscle. Acta. Neuropathol. 73:32-37.
21. Fujita, T., I. Nonaka, and H. Sugita. 1991. Japanese quail and human acid maltase deficiency: a comparative study. Brain Dev. 13:247-255.
22. Kornfeld, S. 1992. Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptors. Annu. Rev. Biochem. 61:307-330.
23. Canfield, W.M., and S. Kornfeld. 1989. The chicken liver cation-independent mannose 6-phosphate receptor lacks the high affinity binding site for insulin-like growth factor II. J. Biol Chem. 264:7100-7103.
24. Yang, Y.W.-H., A.R. Robbins, S.P. Nissley, M. Rechler. 1991. The chick embryo fibroblast cation-independent mannose 6-phosphate receptor is functional and immunologically related to the mammalian insulin-like growth factor-II (IGF-II)/man 6-P receptor but does not bind IGF-II. Endocrinology. 128: 1177-1189.
25. Yang, H.W., M. Mizulani, Y. Hagiwara, T. Kikuchi, J.L.K. Van Hove, and Y.T. Chen. 1996. Recomhinant human acid α-glucosidase corrects acid α-glucosidase deficient human fibroblasts, quail fibroblasts and quail myoblasts. Am. J. Hum. Genet. 59:1197A.
26. Reuser, A.J.J., J.F. Koster, A. Hoogeveen, and H. Galjaard. 1978. Biochemical, immunological, and cell genetic studies in glycogenosis type II. Am. J. Hum. Genet. 30:132-143.
27. Wenger, D.A., and C. Williams. 1991. Screening for lysosomal disorders. In Techniques in Diagnostic Human Biochemical Genetics. A Laboratory Manual. F.A. Hommes, editor. Wiley-Liss, Inc., New York. 587-617.
28. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem. 72:248-254.
29. Vogler, C., M. Sands, A. Higgins, B. Levy, J. Grubb, E.H. Birkemeier, and W.S. Sly. 1993. Enzyme replacement with recombinant β-glucuronidase in the newborn macopolysaccharidosis type VII mouse. Pediatr. Res. 34:837-840.
30. Kakkis, E.D., M.F. McEntee, A. Schmidtchen, E.F. Neufeld, D.A. Ward, R.E. Gompf, S. Kania, C. Bedolla, S.-L. Chien, and R.M. Shull. 1996. Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I. Biochem. Mol. Med. 58:156-167.
31. Crawley, A.C., K.H. Niedzielski, E.L. Isaac, R.C. Davey, S. Byers, J.J. Hopwood. 1997. Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI. J. Clin. Invest. 99:651-662.
32. Ioannou, Y.A., K.M. Zeidner, B. Friedman, and R.J. Desnick. 1996. Fabry disease: enzyme replacement therapy in α-galactasidase A-deficient mice. Am. J. Hum. Genet. 59:A71.
33. Wenk, J., A. Hille, K. von Figura. 1991. Quantitation of Mr 46000 and Mr 300000 mannose 6-phosphate receptors in human cells and tissues. Biochem. Int. 23:723-732.
34. Funk, B., U. Kessles, W. Eisenmenger, A. Hansmann, H.J. Kolb, and W. Kiess. 1992, Expression of the insulin-like growth factor-II/mannose 6-phosphate receptor in multiple human tissues during fetal life and early infancy. J. Clin. Endocrinol. Metab. 75:424-431.
35. Schmidt-Nielsen, K. 1984. Scaling: why is animal size so important? Cambridge University Press, Cambridge. 81 pp.
36. Kunita, R., O. Nakabayashi, J.Y. Wu, Y. Hagiwara, M. Mizutani, M.F. Pennybacker, Y.T. Chen, and T. Kikuchi. 1998. Molecular cloning of acid α-gluccsidase sDNAs of Japanese quail (Coturniy coturnix japornica) and the lack of its mRNA in acid maltase deficient quails. Biochem. Biophys. Acta. In press.